ORIGINAL_ARTICLE
Monocyte Expression of Toll-like Receptor-4 in Patients with Stable Angina Undergoing Percutanoeus Coronary Intervention
Background: Toll like receptors (TLRs) are well recognized players in inflammatory conditions. Among them TLR-4 is involved in chronic inflammatory processes such as formation of atherosclerotic plaques. Objective: The present study was aimed to examine the effects of percutanoeus coronary intervention (PCI) as a revascularization method on monocyte expression of hTLR-4 and on the serum levels of two proinflammatory cytokines (TNF-α and IL-1β). Methods: Blood samples were obtained from 41 patients with stable angina who were candidates for PCI. The samples were collected immediately before and 2h and 4h after PCI. The expression of hTLR-4 on CD14+ monocytes and the serum levels of TNF-α and IL-1β were measured using flowcytometry and ELISA techniques, respectively. Results: By comparing the frequency of circulating hTLR-4+/CD14+ monocytes at different time points, it was observed that PCI procedure up regulates the monocyte expression of hTLR-4 (p<0.05). The increase in expression was associated with the elevation of the serum levels of proinflammatory cytokines (p<0.05). There was a significant correlation between monocyte expression of hTLR-4 and serum levels of TNF-α and IL-1β only before PCI. In spite of parallel increase in the serum levels of proinflammatory cytokines and the monocyte expression of hTLR-4, the correlation did not attain a significant level after PCI intervals. Conclusion: PCI is positively associated with an increase in the monocyte expression of hTLR-4. It is also associated with the elevation in the serum levels of proinflmmatory cytokines. These findings suggest that hTLR-4 monocyte expression may be used as a potential prognostic tool in patients with stable angina undergoing PCI.
https://iji.sums.ac.ir/article_16867_9965abf658a6ae6007e1bb72bf873638.pdf
2012-09-01
149
158
Inflammation
Percutanoeus Coronary Intervention
Toll Like Receptor-4
Stable Angina
Bahador
Bagheri
1
Department of Pharmacology, Faculty of Pharmacy
AUTHOR
Bahram
Sohrabi
2
Shahid Madani Heart Hospital
AUTHOR
Aliakbar
Movassaghpur
3
Hematology Research Centre
AUTHOR
Siminozar
Mashayekhi
4
Department of Clinical Pharmacy, Faculty of Pharmacy
AUTHOR
Afagh
Garjani
5
School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
AUTHOR
Mehriar
Shokri
6
Shahid Madani Heart Hospital
AUTHOR
Mohammad
Noori
7
Shahid Madani Heart Hospital
AUTHOR
Alireza
Garjani
garjania@tbzmed.ac.ir
8
Department of Pharmacology, Faculty of Pharmacy
LEAD_AUTHOR
ORIGINAL_ARTICLE
Toll Like Receptor-4 896A/G Gene Variation, a Risk Factor for Migraine Headaches
Background: The pathogenesis of migraine involves immune-mediated mechanisms in the vascular endothelium. Toll like receptor 4 (TLR-4) is a signaling receptor of innate immunity which plays a role in various neuropathologies related to neuron inflammation. Objective: This case/control study is aimed to investigate whether TLR- 4 896A/G variation is related to migraine headaches in an Iranian population. Methods: A total of 170 migraine patients (130 females, mean age 33.24 ± 11 years) and 170 age, sex, and ethnicity matched healthy controls (118 females, mean age of 31 ± 10 years) were recruited. Genotyping was carried out using the tetra primer amplification refractory mutation system (ARMS)-PCR. Results: The frequency of G allele was higher in migraine patients than the controls (15% vs. 4.7%; p<0.0001). Interestingly, the distribution of heterozygous 896A/G genotype statistically differed between migraineurs and controls (25.3% vs. 8.2%, p=0.00002, OR 3.87, 95% CI; 2.02-7.4). Multivariate logistic regression analysis indicated that G allele in affected female migraineurs is an independent factor associated with increased risk of migraine (OR 3.2, 95% CI 1.23-8.24, p=0.01). Conclusion: Our results showed TLR-4 polymorphism as a genetic risk factor for migraine. However, further studies in different populations are required to elucidate the precise role of TLR-4 896A/G mutation in susceptibility to migraine.
https://iji.sums.ac.ir/article_16868_4efdb17c2bfcdeb0e2da210a158970a2.pdf
2012-09-01
159
167
Female
Genetic Polymorphism
Receptor
Inflammation
migraine
Toll like
Alireza
Rafiei
1
Molecular and Cell Biology Research Center, Sari Medical School
AUTHOR
Mahoud
Abedini
abedinm20@gmail.com
2
Neurology Ward, Department of Internal Medicine, Buali Hospital
LEAD_AUTHOR
Seyed Hamzeh
Hosseini
3
Psychiatry and Behavioral Research Center, Zare Hospital, Sari Medical School, Mazandaran University of Medical Sciences, Sari, Iran
AUTHOR
Zahra
HosseiniKhah
4
Molecular and Cell Biology Research Center, Sari Medical School
AUTHOR
Behrouz
Bazrafshan
5
Neurology Ward, Department of Internal Medicine, Buali Hospital
AUTHOR
Mohsen
Tehrani
drmtehrani@gmail.com
6
Molecular and Cell Biology Research Center, Sari Medical School
AUTHOR
ORIGINAL_ARTICLE
Evaluation of the Immunomodulatory Effect of Curdlan on Maturation and Function of Mouse Spleen-Derived Dendritic Cells
Background: T helper 1 and T helper 17 cells play important roles in immunity against foreign invaders. Differentiation of these Th subsets is affected by state of maturation and cytokines that are produced by dendritic cells (DCs). Curdlan is a linear (1→3)-β- glucan and has shown activity against tumors and infectious agents. Objective: This study aims to investigate whether curdlan plays its role through affecting the maturation and cytokine production by DCs. Methods: DCs were isolated from the spleen of BALB/c mice by MACS method. After an overnight culture of DCs in the presence of curdlan, the expression levels of CD40, CD86, and MHC-II molecules were determined by flow cytometry. The production of cytokines involved in Th1 and Th17 cell differentiation (IL-12 and IL-6, respectively) was also evaluated by ELISA. Lipopolysaccharide (LPS) treated and untreated cells were considered as positive and negative controls, respectively. Results: The results of this study did not show a significant difference in the levels of surface expression of CD40 (p=0.82), CD86 (p=0.79), and MHC class II (p=0.84) molecules upon exposure to curdlan. However, LPS increased the intensity of CD40 expression on dendritic cells (p=0.04). In addition, it was revealed that curdlan-exposed DCs are not able to produce a significant amount of IL-6 and IL-12 cytokines. Conversely, LPS-treated DCs were able to make a significant amount of IL-12 (p=0.005). Conclusion: The results of the present study suggest that curdlan has no effect on Th1 or Th17 differentiation while LPS may induce Th1 deviation by induction of CD40 expression and IL-12 production.
https://iji.sums.ac.ir/article_16869_11cba7154fed7ac46250077be9879014.pdf
2012-09-01
168
174
Dendritic Cells
IL-12
IL-6
CD40
CD86
Mohammad Hashem
Soltani
1
Department of Immunology
AUTHOR
Tahereh
Kalantari
2
Department of Immunology
AUTHOR
Mohammad Hossein
Karimi
karimimh@sums.ac.ir
3
Transplantation Research Center
AUTHOR
Nasrollah
Erfani
erfanin@sums.ac.ir
4
Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Eskandar
Kamali Sarvestani
5
Department of Immunology
AUTHOR
ORIGINAL_ARTICLE
Immunoregulatory Effects of Glutathione During Mesenchymal Stem Cell Differentiation to Hepatocyte-Like Cells
Background: The role of mesenchymal stem cell in cellular therapy is the subject of interest for many researchers. The differentiation potential of MSCs and abilities in modulations of the recipient’s immune system makes them important cells in tissue regenerative studies. MSCs by releasing the proinflammatory cytokines play important role in immunomodulatory systems; however the signaling pathways for releasing of these mediators are not well understood. Glutathione has been shown to play a role in modulation of cytokines in hepatogenic differentiation. Objective: In the current study we aimed to investigate the effects of buthionine sulfoximine (BSO, inhibitor for glutathione synthesis) and N-acetylecystin (NAC, an inhibitor for ROS generation) on proinflammatory cytokines production in a hepatogenic differentiation model. Results: BSO and NAC significantly decreased IL-6 and TNF-α levels at 14 days of differentiation, whereas, NAC decreased the levels of IL-8 at days 2 and 14 of differentiation. Moreover, intracellular glutathione level during the differentiation was depleted. Conclusion: Our current study suggests a novel role of GSH as an immunopharmacological regulatory molecule during hepatogenic differentiation. Finally, this information may shed some light on the understanding of MSCs responses in transplantation and cell therapy in diseases such as chronic hepatic diseases.
https://iji.sums.ac.ir/article_16870_e8d11498b04476821e69272d92c0caa8.pdf
2012-09-01
175
187
Differentiation
glutathione
Tumor Necrosis Factor
Modification
Interleukins
stem cells
Hamid-Reza
Ahmadi-Ashtian
1
Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University
AUTHOR
Abdolamir
Allameh
allameha@modares.ac.ir
2
Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University
LEAD_AUTHOR
Hossein
Rastegar
3
Food and Drug Laboratories, Ministry of Health, Tehran
AUTHOR
Esmaeil
Mortaza
4
Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Sciences, Utrecht University, Utrecht, The Netherland
AUTHOR
Zahir
Saraf
5
Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
AUTHOR
ORIGINAL_ARTICLE
Strong Association of CTLA-4 Variation (CT60A/G) and CTLA-4 Haplotypes with Predisposition of Iranians to Head and Neck Cancer
Background: Variations in Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) affect the expression and function of this protein. Objective: We aimed to investigate the association of +49 A/G (rs231775), +1822 C/T (rs231779) and +6230 A/G (CT60, rs3087243) genetic variations, as well as the merged haplotypes in CTLA-4 gene with susceptibility to, or progression of head and neck cancer. Methods: Eighty patients with confirmed head and neck (HN) cancer (age 54.9 ± 16.1 years) and 85 healthy age/sexmatched controls (age 56.3 ± 12.4 years) were enrolled in the study. Genotypes were investigated by the PCR-RFLP method. Arlequin software package was used to check for Hardy-Weinberg equilibration, and to estimate the haplotypes. Results: At position +6230 A/G (CT60), AA genotype, as well as A allele was significantly decreased in patients with HN cancers than controls (18.8% vs. 40.7%, p=0.004; odds ratio=0.34, and 46.3% vs. 61.7, p=0.007; odds ratio=0.53%, respectively). Nearly the same results were obtained when we compared the subgroup of patients with squamous cell carcinoma of the HN (SCC-HN) with control subjects. The frequencies of genotypes and alleles at other positions were not significantly different between patients and controls, however ACG, GTA and GCA haplotypes emerged from three investigated loci occurred with significantly more frequencies in patients (p<0.0001), while ACA and GTG haplotypes were more frequent among controls (p<0.0001). Significant differences of haplotypes, genotypes and alleles frequencies resisted the Bonferroni correction. Conclusion: Our results suggest that CT60 A allele, as well as ACA and GTG haplotypes in CTLA-4 gene may have protective roles against HN cancer in Iranian population, while ACG, GTA and specially GCA haplotypes may render susceptibility.
https://iji.sums.ac.ir/article_16871_4f8c38b3e5cb7f32a480a335413f0159.pdf
2012-09-01
188
198
Genetic Marker
ctla-4
Haplotype
Head and Neck Cancer
Polymorphism
Squamous cell carcinoma
Nasrollah
Erfani
erfanin@sums.ac.ir
1
Cancer Immunology Group, Shiraz Institute for Cancer Research
AUTHOR
Mohammad Reza
Haghshenas
2
Cancer Immunology Group, Shiraz Institute for Cancer Research
AUTHOR
Mohammad Ali
Hoseini
3
Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Seyed Basi
Hashemi
4
Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Bijan
Khademi
5
Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Abbas
Ghaderi
ghaderia@sums.ac.ir
6
Cancer Immunology Group, Shiraz Institute for Cancer Research
LEAD_AUTHOR
ORIGINAL_ARTICLE
A Clinical Randomized Trial on Endocervical Inflammatory Cytokines and Betamethasone in Prime-Gravid Pregnant Women at Risk of Preterm Labor
Background: There are strong evidences suggesting the secretion of different cytokines in cervical fluid during preterm labor. Betamethasone is widely administered for several reasons in preterm conditions. Objective: To Investigate the possible effect of betamethasone on endocervical cytokine concentration of women at risk of preterm labor. Methods: In a randomized clinical trial of 80 prime-gravid women in preterm labor between 34 and 37 weeks of gestation, cervical fluid was collected. Endocervical concentration of inflammatory cytokines were analyzed before and 48 hours after betamethasone treatment for the evaluation of IL-8, IL-17, IFN-γ and TGF-β. Wilcoxon and Mann-Whitney tests were employed for statistical analysis. χ2 and Student’s t tests were used whenever needed. Results: All the measured cytokines showed significant changes in the betamethasone treated group. IL-17 (p=0.001), IL-8 (p=0.001), and IFN- γ (p<0.05) decreased significantly, while TGF-β had a significant increase (p<0.05). In the patients who delivered before or on the 7th day of admission, IL-17, IL-8, and IFN-γ levels were all significantly higher. However, TGF-β decreased significantly in the same samples in the betamethasone treated group (p<0.05). Conclusion: Betamethasone significantly decreases the endocervical pro-inflammatory cytokine concentrations in patients with preterm labor.
https://iji.sums.ac.ir/article_16872_c63e1530a2fcec39f9de81b59bdef9a1.pdf
2012-09-01
199
207
Cytokine
IL-8
IL-17
IFN-γ
Preterm Delivery
TGF-β
Soghra
Khazardoust
1
Department of Perinatology, Vali-e-Asr Reproductive Health Research Center
AUTHOR
Pouya
Javadian
2
Maternal-Fetal-Neonatal Health Research Centre, Tehran University of Medical Sciences, Tehran
AUTHOR
Bahram
Salmanian
3
Maternal-Fetal-Neonatal Health Research Centre, Tehran University of Medical Sciences, Tehran
AUTHOR
Farnaz
Zandevakil
4
Department of Gynecology, Sanandaj University of Medical Sciences, Sanandaj
AUTHOR
Fatemeh
Abbasalizadeh
5
Department of Gynecology, Tabriz University of Medical Sciences, Tabriz
AUTHOR
Shohreh
Alimohamadi
6
OB-Gyn Departement, Fatemiyeh Hospital, Hamedan University of Medical Sciences, Hamedan
AUTHOR
Sedigheh
Borna
7
Maternal-Fetal-Neonatal Health Research Centre, Tehran University of Medical Sciences, Tehran
AUTHOR
Tooba
Ghazanfari
8
Immunoregulation Research Center, Shahed University, Tehran, Iran
AUTHOR
Sedigheh
Hantoushzadeh
hantoushzadeh@tums.ac.ir
9
Maternal-Fetal-Neonatal Health Research Centre, Tehran University of Medical Sciences, Tehran
LEAD_AUTHOR
ORIGINAL_ARTICLE
Antioxidants and Proinflamatory Cytokines in the Sera of Patients with Cutaneous Leishmaniasis
Background: Leishmania is a significant health problem in many parts of the world. Tumor necrosis factor (TNF) plays an essential role in Leishmania major infections. Objective: To study the pro-inflammatory cytokines and antioxidants in four groups of cutaneous leishmaniasis patients. Methods: 39 patients were divided into four groups of: 1) active (acute phase of treatment); 2) non-healing (received treatment for almost two years without recovery); 3) healing (recovered upon treatment); and 4) healed (previously received treatment and achieved complete remission) patients. Serum levels of pro-inflammatory cytokines (IL-1B, TNF-α, IL-6) and serum antioxidant levels were measured by ELISA and FRAP assays, respectively. Results: While serum antioxidant levels were elevated in the non-healing group, there was no difference among other groups of patients and healthy controls in this regard. Interleukin-1β showed the highest level in the non-healing group followed by the other groups of patients. The mean serum IL-6 level was highest in the non-healing group, but showed no significant change in the other groups. TNF-α and IL-1β levels were non-significantly elevated in the sera of active and non-healing patients. Conclusion: Pro-inflammatory cytokines IL-1β, TNF-α, IL-6 maybe related to the progression of leishmaniasis. Serum antioxidant levels maybe correlated with patient response to drug treatment.
https://iji.sums.ac.ir/article_16873_16efe72738126ce3c96124cd52fb277e.pdf
2012-09-01
208
214
Antioxidants
Cutaneous leishmaniasis
Proinflamatory Cytokines
Afshineh
Latifynia
swt_f@yahoo.com
1
Department of Immunology, Faculty of Medicine
LEAD_AUTHOR
Ali
Khamesipour
2
Leprosy and Dermal Disease Center, Tehran University of Medical Sciences
AUTHOR
Saied
Bokaie
3
Department of Pathobiology, Veterinary Medicine, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Nematollah
Khansari
4
Department of Immunology, Faculty of Medicine
AUTHOR